Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Teva
US Army
Fuji
Colorcon
Healthtrust
AstraZeneca
Merck
Harvard Business School
Farmers Insurance

Generated: August 21, 2017

DrugPatentWatch Database Preview

TIZANIDINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Tizanidine Hydrochloride, and when can generic versions of Tizanidine Hydrochloride launch?

Tizanidine Hydrochloride is a drug marketed by Mylan Pharms Inc, Sun Pharm Inds Inc, Ivax Sub Teva Pharms, Zydus Pharms Usa Inc, Apotex, Epic Pharma Llc, Mylan, Apotex Inc, Par Pharm Inc, Barr, Sandoz Inc, Oxford Pharms, Actavis Elizabeth, Unichem Labs Ltd, Teva, and Dr Reddys Labs Inc. and is included in eighteen NDAs.

The generic ingredient in TIZANIDINE HYDROCHLORIDE is tizanidine hydrochloride. There are eleven drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the tizanidine hydrochloride profile page.

Summary for Tradename: TIZANIDINE HYDROCHLORIDE

Patents:0
Applicants:16
NDAs:18
Suppliers / Packagers: see list44
Bulk Api Vendors: see list53
Clinical Trials: see list2,276
Patent Applications: see list715
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TIZANIDINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: TIZANIDINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Unichem Labs Ltd
TIZANIDINE HYDROCHLORIDE
tizanidine hydrochloride
TABLET;ORAL091283-001Nov 28, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
TIZANIDINE HYDROCHLORIDE
tizanidine hydrochloride
TABLET;ORAL076282-001Dec 16, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Unichem Labs Ltd
TIZANIDINE HYDROCHLORIDE
tizanidine hydrochloride
TABLET;ORAL091283-002Nov 28, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
TIZANIDINE HYDROCHLORIDE
tizanidine hydrochloride
TABLET;ORAL076282-002Dec 16, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
TIZANIDINE HYDROCHLORIDE
tizanidine hydrochloride
CAPSULE;ORAL091502-001Nov 9, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Queensland Health
Julphar
Cerilliant
Teva
US Department of Justice
Deloitte
Healthtrust
Novartis
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot